Antioxidant and hepatic fibrosis-alleviating effects of selenium-modified Bletilla striata polysaccharide
- Guanghui Jiang 1, Haoyue Kong 1, Yuwen Wang 1, Yufei Wang 1, Junjie Zhou 1, Zhezhi Wang 1, Junfeng Niu 1
- Guanghui Jiang 1, Haoyue Kong 1, Yuwen Wang 1
- 1National Engineering Laboratory for Resource Development of Endangered Crude, Drugs in Northwest China, Shaanxi Normal University, Xi'an 710119, China; Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, Xi'an 710119, China; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
- 0National Engineering Laboratory for Resource Development of Endangered Crude, Drugs in Northwest China, Shaanxi Normal University, Xi'an 710119, China; Key Laboratory of Medicinal Resources and Natural Pharmaceutical Chemistry (Shaanxi Normal University), The Ministry of Education, Xi'an 710119, China; College of Life Sciences, Shaanxi Normal University, Xi'an 710119, China.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Modified Bletilla striata polysaccharide (Se-BSP) shows improved efficacy in treating liver fibrosis. This study provides a basis for Se-BSP as a potential therapeutic agent for liver fibrosis.
Area Of Science
- Pharmacology
- Biochemistry
- Hepatology
Background
- Liver fibrosis is a critical precursor to cirrhosis and liver cancer.
- Current treatments for liver fibrosis are limited.
- Bletilla striata polysaccharide (BSP) shows therapeutic potential but is less effective at medium concentrations.
Purpose Of The Study
- To structurally characterize selenized BSP (Se-BSP).
- To evaluate the in vivo efficacy of Se-BSP in alleviating liver fibrosis.
- To improve the therapeutic performance of BSP at medium concentrations.
Main Methods
- Selenization modification of Bletilla striata polysaccharide (BSP).
- Structural characterization of selenized BSP (Se-BSP).
- In vivo evaluation of Se-BSP's anti-fibrotic activity in a liver fibrosis model.
Main Results
- Selenization increased the molecular weight of BSP.
- Se-BSP demonstrated enhanced in vitro antioxidant activity.
- Se-BSP showed improved efficacy in alleviating liver fibrosis at 150 mg/kg compared to BSP.
Conclusions
- Se-BSP exhibits enhanced anti-fibrotic properties compared to native BSP.
- The modified polysaccharide offers a promising therapeutic strategy for liver fibrosis.
- Se-BSP provides a theoretical basis for its application as an anti-liver fibrosis agent.
Related Experiment Videos
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.

